The use of fluorescent in situ hybridization for detection of the t(2;5)(p23;q35) translocation in anaplastic large-cell lymphoma

被引:10
作者
Johnson, PWM
Leek, J
Swinbank, K
Angus, B
Roberts, P
Markham, AF
Selby, PJ
MacLennan, KA
机构
[1] ST JAMES UNIV HOSP,IMPERIAL CANC RES FUND,CANC MED RES UNIT,LEEDS LS9 7TF,W YORKSHIRE,ENGLAND
[2] ST JAMES UNIV HOSP,MOL MED LABS,LEEDS LS9 7TF,W YORKSHIRE,ENGLAND
[3] ST JAMES UNIV HOSP,REG CYTOGENET LAB,LEEDS LS9 7TF,W YORKSHIRE,ENGLAND
[4] ROYAL VICTORIA INFIRM,DEPT HISTOPATHOL,NEWCASTLE TYNE NE1 4LP,TYNE & WEAR,ENGLAND
关键词
anaplastic large-cell lymphoma; fluorescent in situ hybridization; Hodgkin's disease; Ki-1; lymphoma; PCR;
D O I
10.1023/A:1008234301024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Anaplastic large-cell lymphoma (ALCL) is a recently recognized, distinctive type of non-Hodgkin's lymphoma characterized by anaplastic large-cell cytology and expression of a member of the TNF-receptor family CD30. A characteristic chromosomal translocation has been identified in ALCL of Tor null-cell lineage which juxtaposes a novel tyrosine kinase (anaplastic lymphoma kinase, ALK) located at 2p23 with the nucleophosmin gene (NPM) at 5q35. A chimeric mRNA transcript is produced, and the translocation results in constitutive expression of a truncated form of the ALK protein, p80. There is controversy concerning whether or not the translocation occurs in Hodgkin's disease. The aim of this study was to develop a methodology for fluorescent in situ hybridization (FISH) to detect the t(2;5)(p23;q35), and to compare the results with conventional cytogenetics, reverse-transcriptase PCR and immunostaining for the p80 protein. Patients and methods: Twenty-five cases of malignant lymphoma (II ALCL and 14 HD) were studied. Immunohistochemistry was performed to confirm the diagnosis and for analysis of p80 expression. Conventional cytogenetics were analyzed on C-banded metaphase spreads. FISH was performed using whole chromosome paints for chromosomes 2 and 5 on metaphase spreads and YAC probes for interphase nuclei. Reverse-transcriptase PCR using primers for ALK and NPM was used to amplify the translocation breakpoint in extracted mRNA. Results: Among 11 cases of ALCL examined by FISH, the translocation was detected in 4. Two of these cases also had RT-PCR and p80 staining performed, with positive results. Among 7 cases where the t(2;5) was not detected by FISH, 3 cases were examined by RT-PCR with negative results and 4 cases by p80 staining, also negative. The RT-PCR was negative in all 14 cases of Hodgkin's disease, 4 of which were also examined by FISH and found to be negative. Conclusion: Fluorescent in sib hybridization is a useful method for detection of the t(2;5)(p23;q35) in anaplastic large-cell lymphoma. The results concur with those of RT-PCR for the chimeric transcript and immunostaining for the p80 protein. The frequency with which the translocation was found was 36% in this small series, and no evidence of the translocation was found in cases of Hodgkin's disease.
引用
收藏
页码:65 / 69
页数:5
相关论文
共 29 条
[1]   A 3.5 GENOME EQUIVALENT MULTIACCESS YAC LIBRARY - CONSTRUCTION, CHARACTERIZATION, SCREENING AND STORAGE [J].
ANAND, R ;
RILEY, JH ;
BUTLER, R ;
SMITH, JC ;
MARKHAM, AF .
NUCLEIC ACIDS RESEARCH, 1990, 18 (08) :1951-1956
[2]   MORPHOLOGY IN KI-1(CD30) - POSITIVE NON-HODGKINS-LYMPHOMA IS CORRELATED WITH CLINICAL-FEATURES AND THE PRESENCE OF A UNIQUE CHROMOSOMAL ABNORMALITY, T(2 - 5)(P23 - Q35) [J].
BITTER, MA ;
FRANKLIN, WA ;
LARSON, RA ;
MCKEITHAN, TW ;
RUBIN, CM ;
LEBEAU, MM ;
STEPHENS, JK ;
VARDIMAN, JW .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1990, 14 (04) :305-316
[3]  
BULLRICH F, 1994, CANCER RES, V54, P2873
[4]   KI-1-POSITIVE LARGE CELL LYMPHOMA - A CLINICOPATHOLOGICAL STUDY OF 41 CASES [J].
CHOTT, A ;
KASERER, K ;
AUGUSTIN, I ;
VESELY, M ;
HEINZ, R ;
OEHLINGER, W ;
HANAK, H ;
RADASZKIEWICZ, T .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1990, 14 (05) :439-448
[5]   MOLECULAR-DETECTION OF THE (2-5) TRANSLOCATION OF NON-HODGKINS-LYMPHOMA BY REVERSE TRANSCRIPTASE-POLYMERASE CHAIN-REACTION [J].
DOWNING, JR ;
SHURTLEFF, SA ;
ZIELENSKA, M ;
CURCIOBRINT, AM ;
BEHM, FG ;
HEAD, DR ;
SANDLUND, JT ;
WEISENBURGER, DD ;
KOSSAKOWSKA, AE ;
THORNER, P ;
LORENZANA, A ;
LADANYI, M ;
MORRIS, SW .
BLOOD, 1995, 85 (12) :3416-3422
[6]   TRANSCRIPTS OF THE NPM-ALK FUSION GENE IN ANAPLASTIC LARGE-CELL LYMPHOMA, HODGKINS-DISEASE, AND REACTIVE LYMPHOID LESIONS [J].
ELMBERGER, PG ;
LOZANO, MD ;
WEISENBURGER, DD ;
SANGER, W ;
CHAN, WC .
BLOOD, 1995, 86 (09) :3517-3521
[7]  
ELMSLIE EA, 1994, HUMAN GENET, V93, P513
[8]   CD30 (Ki-1)-positive malignant lymphomas: Clinical, immunophenotypic, histologic, and genetic characteristics and differences with Hodgkin's disease [J].
Filippa, DA ;
Ladanyi, M ;
Wollner, N ;
Straus, DJ ;
OBrien, JP ;
Portlock, C ;
Gangi, M ;
Sun, M .
BLOOD, 1996, 87 (07) :2905-2917
[9]  
FISCHER P, 1988, BLOOD, V72, P234
[10]   CLINICAL-FEATURES OF 31 PATIENTS WITH KI-1 ANAPLASTIC LARGE-CELL LYMPHOMA [J].
GREER, JP ;
KINNEY, MC ;
COLLINS, RD ;
SALHANY, KE ;
WOLFF, SN ;
HAINSWORTH, JD ;
FLEXNER, JM ;
STEIN, RS .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (04) :539-547